HEALTH MINISTER STEPHEN Donnelly has said there is emerging evidence that Ozempic is a “wonder drug”, stating that he is open to expanding the medication to more groups.
The drug contains semaglutide, which is effective in regulating blood sugar and insulin for people with type 2 diabetes and in suppressing appetite for people with obesity.
Striking new findings from the Yale School of Medicine show that drugs containing semaglutide, such as Ozempic and Wegovy, have more far-reaching health benefits than first thought and that they can slow down the biological ageing process, allowing people to live in better health for longer.
Writing for The Journal recently, Cardiologist Professor Robert Byrne said the new evidence suggesting drugs like Ozempic can slow down the ageing process is worth celebrating.
Asked about the NHS in the UK giving consideration to opening the drug up to millions of more people on the back of the new research, and …